China $9 billion IPO plans stalled amid COVID outbreak – filings, estimate

SHANGHAI (Reuters) – A wave of Chinese companies have halted domestic listing plans, filings show, as the country’s biggest coronavirus outbreak in two years hampered due diligence and information gathering, affecting an estimated $9 billion-plus in fundraising.